Profile | GDS2987 / GI_21389358-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 39.3 | 68 |
GSM215244 | HMVEC_vehicle_rep2 | 17.9 | 42 |
GSM215253 | HMVEC_vehicle_rep3 | 39.7 | 68 |
GSM215254 | HMVEC_atorvastatin_rep1 | 33 | 61 |
GSM215282 | HMVEC_atorvastatin_rep3 | 36.7 | 61 |
GSM215344 | HMVEC_atorvastatin_rep2 | 51.3 | 68 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 32.2 | 52 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 40.9 | 60 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 73.6 | 70 |
GSM215294 | HMVEC_SLx2119_rep1 | 53.7 | 71 |
GSM215295 | HMVEC_SLx2119_rep2 | 58 | 68 |
GSM215296 | HMVEC_SLx2119_rep3 | 46.1 | 59 |
GSM215297 | PASMC_vehicle_rep1 | 74.3 | 69 |
GSM215298 | PASMC_vehicle_rep2 | 69.7 | 68 |
GSM215310 | PASMC_vehicle_rep3 | 85.8 | 72 |
GSM215311 | PASMC_atorvastatin_rep1 | 96.2 | 74 |
GSM215312 | PASMC_atorvastatin_rep2 | 47.9 | 59 |
GSM215313 | PASMC_atorvastatin_rep3 | 64.6 | 66 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 49.1 | 61 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 69.5 | 70 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 72.8 | 70 |
GSM215327 | PASMC_SLx2119_rep1 | 29.4 | 46 |
GSM215328 | PASMC_SLx2119_rep2 | 36.4 | 54 |
GSM215329 | PASMC_SLx2119_rep3 | 75 | 71 |
GSM215330 | Fibroblasts_vehicle_rep1 | 7 | 17 |
GSM215331 | Fibroblasts_vehicle_rep2 | 9.9 | 28 |
GSM215332 | Fibroblasts_vehicle_rep3 | ||
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 9 | 25 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 22.9 | 48 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | ||
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 11.5 | 31 |
GSM215341 | Fibroblasts_SLx2119_rep3 |